RhBMP-2/ACS: Cost effective alternative to ICBG in posterolateral lumbar spinal fusion
The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusionSpine J. 2008 May-Jun;8(3):443-8. Epub 2007 May 15.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
102 patients, over 60 years old, scheduled to undergo an instrumented posterolateral lumbar spine fusion were randomized to receive recombinant bone morphogenetic protein rhBMP-2/ACS or Iliac crest bone graft (ICBG) during the procedure. The use of BMP is a significant cost burden to the patient and hospital. However, upon meticulous calculation of the aggregate cost in the 3 month period after su...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue